Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis

Antonio Craxi, Rosaria Maria Pipitone, Calogero Camma', Antonio Pinto, Antonino Tuttolomondo, Stefania Grimaudo, Salvatore Petta, Vito Di Marco, Vincenza Calvaruso, Marcello Ciaccio, Anna Licata, Luca Rinaldi, Riccardo Nevola, Anna Ludovica Fracanzani, Aldo Marrone, Luca Valenti, Silvia Fargion, Luigi Elio Adinolfi, Daniele Torres, Francesca RiniRosalia Caldarella

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Abstract

Recent studies suggest an association between HCV infection and cardiovascular damage, including carotid atherosclerosis, with a possible effect of HCV clearance on cardiovascular outcomes. We aimed to examine whether HCV eradication by direct antiviral agents (DAA) improves carotid atherosclerosis in HCV-infected patients with advanced fibrosis/compensated cirrhosis.
Original languageEnglish
Number of pages0
JournalJournal of Hepatology
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Hepatology

Fingerprint Dive into the research topics of 'Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis'. Together they form a unique fingerprint.

Cite this